Music has shown promise in easing symptoms of neurodegenerative disease — but don’t expect a prescribed playlist anytime soon ...

Daniella Lorentsen strutted down the model runway in Farmingdale to the cheers and applause of hundreds, feeling confident ...

Yusuf's journey from multiple seizures to a tumor diagnosis and successful treatment, highlighting the importance of early ...

Scientists at the University Medical Center Hamburg-Eppendorf (UKE) and Heidelberg University Hospital (UKHD) have ...

Despite its growing role in tracking MS activity, serum neurofilament light chain lacks diagnostic specificity, experts say.

Roche shares new data showing its MS drug fenebrutinib maintained low relapse rates and no disability progression in patients ...

The following is a summary of “Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study,” published in the May 2025 issue of European Journal of ...

Multiple sclerosis is a progressive condition where the brain and the spinal cord get affected due to damage to the myelin sheath. This further causes a lot of neurological symptoms, such as vision ...

Multiple sclerosis is a chronic condition that currently does not have a cure. Over 1.8 million people worldwide live with MS. Symptoms vary from person to person but can include numbness ...

Roche has shared long-term phase 2 data on its BTK inhibitor fenebrutinib in relapsing multiple sclerosis (MS), | Roche has shared long-term phase 2 data on its BTK inhibitor fenebrutinib in relapsing ...

A specialized T2*-weighted MRI scan using the "rule of six" can diagnose multiple sclerosis in 8 minutes by detecting characteristic brain lesions, eliminating the need for a lumbar puncture.

Current care in multiple sclerosis (MS) primarily relies on infrequently obtained data such as magnetic resonance imaging, clinical laboratory tests or clinical history, resulting in subtle changes ...